$23.9B
$9.75 Million
0.02% of portfolio
22,751
Q3 2024
Added 16.83%
$31.8B
$9.07 Million
0.02% of portfolio
88,517
Q3 2024
Added 62.06%
-
$7.63 Million
0.02% of portfolio
-
Q3 2024
New
$62.2B
$8.56 Million
0.02% of portfolio
30,432
Q3 2024
Added 0.62%
$22.6B
$7.88 Million
0.02% of portfolio
75,069
Q3 2024
Reduced 20.8%
$14.7B
$9.39 Million
0.02% of portfolio
175,542
Q3 2024
Reduced 0.31%
$9.15B
$9.37 Million
0.02% of portfolio
81,935
Q3 2024
Added 14.63%
$30.9B
$8.12 Million
0.02% of portfolio
148,603
Q3 2024
Added 5.34%
-
$9.26 Million
0.02% of portfolio
-
Q3 2024
Reduced 20.83%
-
$6.83 Million
0.02% of portfolio
-
Q3 2024
New
$22.1B
$9.99 Million
0.02% of portfolio
55,418
Q3 2024
Reduced 52.08%
-
$2.3 Million
0.01% of portfolio
-
Q1 2024
Reduced 24.24%
$5.71B
$2.39 Million
0.01% of portfolio
39,227
Q3 2024
Reduced 9.95%
$49.1B
$2.79 Million
0.01% of portfolio
27,812
Q3 2024
Added 0.6%
-
$2.11 Million
0.01% of portfolio
-
Q2 2024
New
$30.7B
$4.44 Million
0.01% of portfolio
33,768
Q3 2024
Added 7.26%
$12.6B
$3.12 Million
0.01% of portfolio
28,286
Q3 2024
Reduced 1.04%
-
$4.13 Million
0.01% of portfolio
-
Q1 2024
Added 21.43%
-
$4.48 Million
0.01% of portfolio
-
Q2 2024
Reduced 20.0%
$37.2B
$4.56 Million
0.01% of portfolio
14,385
Q3 2024
Reduced 2.0%
$30.3B
$2.03 Million
0.01% of portfolio
6,910
Q3 2024
Added 2.4%
$41B
$5.02 Million
0.01% of portfolio
56,335
Q3 2024
Added 14.11%
-
$4.81 Million
0.01% of portfolio
-
Q4 2020
New
-
$3.76 Million
0.01% of portfolio
-
Q2 2024
Reduced 33.33%
$33.3B
$2.81 Million
0.01% of portfolio
5,281
Q3 2024
Added 3.49%
$20.6B
$3.58 Million
0.01% of portfolio
101,630
Q3 2024
Added 108.05%
$13B
$3.55 Million
0.01% of portfolio
15,494
Q3 2024
Added 13.11%
$46B
$3.85 Million
0.01% of portfolio
26,010
Q3 2024
Added 3.49%
$7.76B
$2.27 Million
0.01% of portfolio
14,921
Q3 2024
Added 7.39%
Biomarin Pharmaceutical Inc
-
$2.75 Million
0.01% of portfolio
-
Q2 2024
Reduced 34.09%
-
$5.96 Million
0.01% of portfolio
-
Q2 2024
Reduced 14.49%
$865M
$4.46 Million
0.01% of portfolio
256,468
Q3 2024
Reduced 6.36%
-
$4.32 Million
0.01% of portfolio
-
Q3 2024
Reduced 33.59%
-
$2.26 Million
0.01% of portfolio
-
Q4 2023
Reduced 54.55%
$9.75B
$3.51 Million
0.01% of portfolio
25,001
Q3 2024
Reduced 1.47%
-
$2.87 Million
0.01% of portfolio
-
Q1 2024
New
$17.9B
$3.67 Million
0.01% of portfolio
42,716
Q3 2024
Reduced 58.46%
-
$2.09 Million
0.01% of portfolio
-
Q1 2022
New
$23.8B
$3.63 Million
0.01% of portfolio
16,050
Q3 2024
Reduced 2.7%
-
$5 Million
0.01% of portfolio
-
Q3 2024
Reduced 9.28%
Ionis Pharmaceuticals Inc
-
$2.58 Million
0.01% of portfolio
-
Q2 2024
New
$4.25B
$5.22 Million
0.01% of portfolio
280,711
Q3 2024
New
Integra Lifesciences Hldgs C
-
$2.85 Million
0.01% of portfolio
-
Q2 2024
Reduced 33.33%
$12.2B
$3.69 Million
0.01% of portfolio
32,984
Q3 2024
Reduced 6.89%
$13.5B
$4.45 Million
0.01% of portfolio
40,285
Q3 2024
Reduced 13.58%
-
$5.01 Million
0.01% of portfolio
-
Q3 2024
New
-
$3.5 Million
0.01% of portfolio
-
Q4 2023
Reduced 37.88%
$19B
$2.19 Million
0.01% of portfolio
7,552
Q3 2024
Reduced 1.73%
$11.9B
$2.71 Million
0.01% of portfolio
22,397
Q3 2024
Reduced 51.75%
$11.4B
$3.3 Million
0.01% of portfolio
19,896
Q3 2024
Added 1.07%